PT3052194T - Método veterinário para induzir emese - Google Patents

Método veterinário para induzir emese

Info

Publication number
PT3052194T
PT3052194T PT147928469T PT14792846T PT3052194T PT 3052194 T PT3052194 T PT 3052194T PT 147928469 T PT147928469 T PT 147928469T PT 14792846 T PT14792846 T PT 14792846T PT 3052194 T PT3052194 T PT 3052194T
Authority
PT
Portugal
Prior art keywords
veterinary method
inducing emesis
emesis
inducing
veterinary
Prior art date
Application number
PT147928469T
Other languages
English (en)
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of PT3052194T publication Critical patent/PT3052194T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT147928469T 2013-09-30 2014-09-29 Método veterinário para induzir emese PT3052194T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361884924P 2013-09-30 2013-09-30

Publications (1)

Publication Number Publication Date
PT3052194T true PT3052194T (pt) 2021-07-06

Family

ID=51845431

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147928469T PT3052194T (pt) 2013-09-30 2014-09-29 Método veterinário para induzir emese

Country Status (21)

Country Link
US (1) US10092510B2 (pt)
EP (1) EP3052194B1 (pt)
JP (1) JP6382993B2 (pt)
KR (1) KR102277168B1 (pt)
CN (1) CN105592889B (pt)
AU (1) AU2014326576B2 (pt)
BR (1) BR112016007057B1 (pt)
CA (1) CA2922913C (pt)
DK (1) DK3052194T3 (pt)
ES (1) ES2878146T3 (pt)
HR (1) HRP20211308T1 (pt)
HU (1) HUE056109T2 (pt)
LT (1) LT3052194T (pt)
MX (1) MX370302B (pt)
NZ (1) NZ717434A (pt)
PL (1) PL3052194T3 (pt)
PT (1) PT3052194T (pt)
RU (1) RU2693492C2 (pt)
SI (1) SI3052194T1 (pt)
WO (1) WO2015044504A1 (pt)
ZA (1) ZA201601468B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3737378T3 (da) * 2018-01-12 2023-05-30 Orion Corp Palonosetron-øjendråber til behandling eller forebyggelse af kvalme og opkastning
US20230071557A1 (en) * 2020-02-03 2023-03-09 Orion Corporation Stable pharmaceutical compositions of ropinirole

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336490C (en) * 1988-06-03 1995-08-01 Paul Michael Iuvone Pharmacological treatment of ocular development
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
RU2470635C2 (ru) * 2007-05-11 2012-12-27 Сантен Фармасьютикал Ко., Лтд. Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза

Also Published As

Publication number Publication date
ZA201601468B (en) 2017-06-28
MX2016003904A (es) 2016-06-17
CN105592889A (zh) 2016-05-18
LT3052194T (lt) 2021-07-12
SI3052194T1 (sl) 2021-09-30
EP3052194A1 (en) 2016-08-10
CN105592889B (zh) 2019-06-21
BR112016007057A2 (pt) 2017-08-01
HRP20211308T1 (hr) 2021-11-26
HUE056109T2 (hu) 2022-01-28
BR112016007057B1 (pt) 2023-04-11
RU2016116810A (ru) 2017-11-10
NZ717434A (en) 2019-03-29
PL3052194T3 (pl) 2021-12-13
JP6382993B2 (ja) 2018-08-29
AU2014326576B2 (en) 2019-03-14
KR20160062130A (ko) 2016-06-01
RU2016116810A3 (pt) 2018-07-02
KR102277168B1 (ko) 2021-07-15
US20160206555A1 (en) 2016-07-21
EP3052194B1 (en) 2021-06-16
DK3052194T3 (da) 2021-07-26
ES2878146T3 (es) 2021-11-18
MX370302B (es) 2019-12-09
RU2693492C2 (ru) 2019-07-03
CA2922913A1 (en) 2015-04-02
JP2016531940A (ja) 2016-10-13
CA2922913C (en) 2021-09-07
WO2015044504A1 (en) 2015-04-02
AU2014326576A1 (en) 2016-03-17
US10092510B2 (en) 2018-10-09

Similar Documents

Publication Publication Date Title
EP2959413A4 (en) METHOD OF COMPLIANCE FOR CYBER-PHYSICAL SYSTEM
GB2535905B (en) Apparatus for repairing a pipe
GB2513431B (en) Method for creating a label
PT3123975T (pt) Corpo digitalizador
HK1224401A1 (zh) 用於評估證件的方法
GB201421562D0 (en) Method for preparing a sorbent
EP3073158A4 (en) METHOD FOR PRODUCING SEALING DEVICE
GB201421563D0 (en) Method for preparing a sorbent
GB201306544D0 (en) Method for releasing overlaps
DK3533325T3 (en) Process for forming a coverbraided ribline
GB201421564D0 (en) Method for preparing a sorbent
PL2941509T3 (pl) Sposób wytwarzania pokrycia
PL3041638T3 (pl) Pozycjoner do rur
GB201300528D0 (en) Apparatus for manufacturing a container
ZA201601468B (en) A veterinary method for inducing emesis
HRP20160528T1 (hr) Postupak za rukovanje aparatom za grijanje
SG11201602178QA (en) Tool for removing collars
PL3054775T3 (pl) Sposób wytwarzania środka do smarowania
SG11201510638XA (en) Process for locating devices
PL2821714T3 (pl) Urządzenie do ogrzewania budynku
GB2511513B (en) Apparatus for providing a line
GB201321620D0 (en) Apparatus for making a selection
GB201315800D0 (en) Repair method
PT2892308T (pt) Processo para o preenchimento de um pino de ligação de passagem
ZA201500300B (en) A press-bending apparatus